undamentalytics Newsletter
Sign in

Xenetic Biosciences, Inc. balance sheet

At the end of fiscal 2025, Xenetic Biosciences, Inc. had total assets of $8.4m, total liabilities of $968,025 and shareholders' equity of $7.4m. It held $7.9m in cash against $0 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents————461101218139686
Receivables000030—————————
Total current assets125348611112191410787
Goodwill443333390——————
Total assets251916172119142213201511787
Accounts payable011211110000000
Total current liabilities143722211111111
Total debt000000000000000
Total liabilities5761055541111111
Shareholders' equity21131071614101712181410676
Shares outstanding——————————2m2m2m—2m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: UPB vs XBIOALGS vs XBIODYAI vs XBIO

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Xenetic Biosciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Xenetic Biosciences, Inc.